Ionis Pharmaceuticals Inc’s recent filing unveils that its Officer Swayze Eric acquired Company’s shares for reported $0.75 million on Jan 16 ’26. In the deal valued at $76.23 per share,9,884 shares were bought.
Then, Baroldi Joseph bought 6,999 shares, generating $559,920 in total proceeds.
Before that, BENNETT C FRANK bought 8,977 shares. Ionis Pharmaceuticals Inc shares valued at $684,264 were divested by the Officer at a price of $76.22 per share.
JP Morgan upgraded its Ionis Pharmaceuticals Inc [IONS] rating to an Overweight from a a Neutral in a research note published recently. A number of analysts have revised their coverage, including Goldman’s analysts, who increased its forecast for the stock in late September from “a Sell” to “a Neutral”. BMO Capital Markets also remained covering IONS and has increased its forecast on September 03, 2025 with a “an Outperform” recommendation from previously “Market perform” rating. Morgan Stanley revised its rating on July 31, 2025. It rated IONS as “an Overweight” which previously was an “an Equal-weight”.
Price Performance Review of IONS
On Friday, Ionis Pharmaceuticals Inc [NASDAQ:IONS] saw its stock fall -1.14% to $76.33. Over the last five days, the stock has lost -4.94%. Ionis Pharmaceuticals Inc shares have risen nearly 129.84% since the year began. Nevertheless, the stocks have fallen -3.51% over the past one year.
How much short interest is there in Ionis Pharmaceuticals Inc?
A steep rise in short interest was recorded in Ionis Pharmaceuticals Inc stocks on 2025-12-31, dropping by -0.74 million shares to a total of 14.89 million shares. Yahoo Finance data shows the prior-month short interest on 2025-11-28 was 15.63 million shares. There was a decline of -4.98%, which implies that there is a negative sentiment for the stock.
